PL BioScience
Series A in 2024
PL BioScience GmbH is a biotechnology company based in Aachen, Germany, specializing in the development and manufacture of cell culture products derived from human platelet lysate. Founded in 2015, the company provides a range of products tailored for stem cell research, including research grade, GMP grade, and customized formulations, as well as fibrinogen-depleted and gamma-irradiated products. PL BioScience also offers advanced 2D and 3D cell culture solutions, cell culture medium kits, primary cells, and related support services. Its offerings are designed to facilitate safe and reproducible cellular growth for basic research, cellular therapeutics, and clinical applications. Through its online platform, PL BioScience meets the increasing demand for high-quality cell culture media essential for various stages of research and development within the biotech and life sciences sectors.
Cultimate
Seed Round in 2024
Cultimate Foods is a pioneering cellular agriculture company specializing in the development of cultivated fat for hybrid alt-meat products. The company's unique technological approach involves 3D cultivation, replicating the structure of animal fat tissue and reducing production costs. Cultimate Foods aims to provide consumers with a more efficient, sustainable, and ethical way to enjoy meat-like experiences while minimizing environmental impact.
traceless materials
Series A in 2023
traceless materials is offering a holistically sustainable alternative to plastics and bioplastics. With our first-of-a-kind biomaterial it’s our mission to contribute to solving global plastic pollution. Our innovative technology filed for patent allows to use food production residues to produce materials that are compostable under natural composting conditions. While bio-based, our materials don’t compete with food nor cause land-use-change, don’t need hazardous additives or solvents and have up to 95% lower CO2 emissions. Our materials are neither chemically modified nor synthetically polymerized, therefore they will not fall under the EU Single Use Plastic Directive. Follow us on our journey, and become a part of the solution, not the pollution!
Revoltech
Pre Seed Round in 2022
Revoltech is a company focused on innovative textile technology aimed at revolutionizing material production. Its flagship product, LOVR, represents the world's first plastic-free and entirely plant-based leather alternative, crafted from agricultural residues. By utilizing fibrous agricultural byproducts and other plant-based materials, Revoltech promotes a sustainable and transparent approach to manufacturing, fostering a regional circular economy. The company's commitment to eco-friendly solutions positions it at the forefront of the shift towards sustainable materials in various industries.
FibreCoat
Venture Round in 2021
FibreCoat GmbH specializes in manufacturing thermoplastic-coated glass fibres, primarily serving the automotive and consumer sectors. The company's unique direct coating process enables cost savings and reduced production times while enhancing product specifications for fibre composite applications. FibreCoat's offerings include metal-coated fibres designed for electromagnetic interference shielding, heat sinks, reinforcement of cast aluminium parts, and conductive yarns in smart textiles.
Actome is a biotechnology company that specializes in the development of advanced interactome technology aimed at enhancing life science research and personalized medicine. The firm employs a proprietary method that allows for the detection of single protein molecules and their interaction complexes. This technology translates the status of proteins into DNA barcodes through the use of DNA-labeled antibodies, facilitating detailed molecular biological research. Actome's innovations enable clients to analyze protein quantification, interactions, and post-translational modifications within biological samples, thereby contributing to advancements in pharmaceuticals and tailored therapeutic solutions.
Placeme
Seed Round in 2021
Placeme is a technology company based in Warsaw, Poland, that develops a data-as-a-service application focused on location services. The platform enables businesses, particularly in retail and fast-moving consumer goods (FMCG), to predict customer behavior and assess sales potential at specific addresses. By leveraging big data and machine learning, Placeme provides users with an easy-to-use online tool that delivers complex insights with minimal effort. The application helps businesses identify optimal locations for new ventures and potential contractors by analyzing vast amounts of data. Additionally, it offers insights into consumer habits by tracking customer journeys across both online and offline channels. Through geotargeted advertising, Placeme assists companies in reaching defined consumer demographics, ultimately enhancing their marketing strategies and driving revenue growth.
traceless materials
Seed Round in 2021
traceless materials is offering a holistically sustainable alternative to plastics and bioplastics. With our first-of-a-kind biomaterial it’s our mission to contribute to solving global plastic pollution. Our innovative technology filed for patent allows to use food production residues to produce materials that are compostable under natural composting conditions. While bio-based, our materials don’t compete with food nor cause land-use-change, don’t need hazardous additives or solvents and have up to 95% lower CO2 emissions. Our materials are neither chemically modified nor synthetically polymerized, therefore they will not fall under the EU Single Use Plastic Directive. Follow us on our journey, and become a part of the solution, not the pollution!
b.fab
Venture Round in 2021
B.fab is a biotechnology company founded in 2018 in Dortmund, Nordrhein-Westfalen, that specializes in converting carbon dioxide and hydrogen derived from renewable energy into sustainable biotechnological value chains. Central to its processes is formate, which serves as a mediator for binding and storing CO2 and hydrogen in liquid form. The company employs synthetic biology to design specific metabolic pathways that facilitate the conversion of formate into valuable chemicals, such as proteins for aquaculture and biopolymer building blocks. Utilizing both anaerobic and aerobic microbial production hosts, B.fab offers flexibility in process design tailored to meet diverse product requirements. The company integrates laboratory automation and high-throughput experimentation with advanced bioprocess development, enabling it to create new bioprocesses efficiently and within compressed timelines.
Nano-Join
Venture Round in 2020
Nano-Join GmbH, established in 2015 and headquartered in Berlin, Germany, specializes in developing and distributing silver sinter paste for power electronics applications. The company caters primarily to optoelectronics, e-mobility, and renewable energy sectors, offering interconnecting materials designed to enhance thermal and electrical conductivity in these industries.
Belano medical
Venture Round in 2020
Belano Medical is a company that specializes in the development and distribution of a range of healthcare products, including skin care, pharynx and throat care, mouth care, stomach care, and wound infection treatments. The company focuses on advancing therapeutic approaches for medical skin care and aims to provide innovative solutions for the prevention of diseases and to support healing processes. By leveraging research in human microbiome, Belano Medical seeks to offer new treatment options for conditions that have not been effectively addressed in the past. In addition to its product offerings, the company also provides tests and analyses to ensure the efficacy of its solutions.
SenseUp
Venture Round in 2017
SenseUp is a biotech company founded in 2015 and headquartered in Jülich, North Rhine-Westphalia. The company specializes in the development of microbial production strains aimed at enhancing the biotechnological production of amino acids, peptides, and proteins. Utilizing advanced genomics, transcriptomics, and metabolomics, SenseUp offers both de-novo construction and optimization of existing strains. A key feature of its technology is the unique biosensor capability, which allows for the optical determination of microbial strain productivity at the single-cell level. This innovative approach enables the rapid analysis of extensive cell libraries under relevant process conditions, thereby facilitating the creation of customized production strains, media formulations, and processes tailored to the specific needs of clients.